Cargando…

Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305

Objective measures of adherence for antiretrovirals used as pre-exposure prophylaxis (PrEP) are critical for improving preventative efficacy in both clinical trials and real-world application. Current objective adherence measures either reflect only recent behavior (eg days for plasma or urine) or c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosen, Elias P., White, Nicole, Gilliland, William M., Gerona, Roy R., Gandhi, Monica, Amico, K. Rivet, Mayer, Kenneth H., Gulick, Roy M., Kashuba, Angela D. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289441/ https://www.ncbi.nlm.nih.gov/pubmed/37352285 http://dx.doi.org/10.1371/journal.pone.0287449

Ejemplares similares

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305
por: Kapadia, Shashi N., et al.
Publicado: (2018)

Five-Year Safety Evaluation of Maraviroc in HIV-1–Infected Treatment-Experienced Patients
por: Gulick, Roy M., et al.
Publicado: (2014)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Nucleotide- and Protein-Dependent Functions of Actg1
por: Sundby, Lauren J., et al.
Publicado: (2022)

P069. Osmophobia in children with headache
por: Bosetti, Francesca M, et al.
Publicado: (2015)

A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population
por: Lee, Jeongeun, et al.
Publicado: (2022)

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
por: Illuzzi, Giuditta, et al.
Publicado: (2022)

Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis
por: Gerona, Roy, et al.
Publicado: (2016)

Title unknown, CERN-ALEPH-98-069
por: CERN. Geneva. ALEPH
Publicado: (1998)

Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067
por: Mannheimer, Sharon, et al.
Publicado: (2019)

P-069: EFFECTS OF QUERCETIN IN TRANSCRIPTIONAL REGULATION OF FETAL HEMOGLOBIN
por: B., CANTEIRO, et al.
Publicado: (2022)

Autosomal Recessive ACTG2-Related Visceral Myopathy in Brothers
por: Mori, Mari, et al.
Publicado: (2022)

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305
por: Zheng, Jingcao, et al.
Publicado: (2023)

Maraviroc in the treatment of HIV infection
por: Ray, Neelanjana
Publicado: (2009)

Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study
por: Franks, Julie, et al.
Publicado: (2017)

Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework
por: Amico, K. Rivet, et al.
Publicado: (2016)

Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)
por: Bosch, Ronald J, et al.
Publicado: (2010)

AB069. The observation on affection of TURED on obstructive azoospermia
por: Wang, Jingqi, et al.
Publicado: (2015)

Expanding the genotypic spectrum of ACTG2-related visceral myopathy
por: James, Kiely N., et al.
Publicado: (2021)

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)

The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin
por: Dellavedova, Giulia, et al.
Publicado: (2023)

SUN-LB069 Pituitary Apoplexy and Pregnancy: Case Report
por: LOTO, MONICA, et al.
Publicado: (2019)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment
por: Stellbrink, Hans-Jürgen, et al.
Publicado: (2016)

ACTG1 and TLR3 are biomarkers for alcohol-associated hepatocellular carcinoma
por: Gao, Bing, et al.
Publicado: (2019)

RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2019)

ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis
por: Hahn, Jong Woo, et al.
Publicado: (2022)

Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
por: Velloza, Jennifer, et al.
Publicado: (2019)

Implications of maraviroc and/or rapamycin in a mouse model of fragility
por: Pérez-Martínez, Laura, et al.
Publicado: (2020)

Maraviroc: the evidence for its potential in the management of HIV
por: Profit, Louise
Publicado: (2007)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
por: Gonzalez-Serna, Alejandro, et al.
Publicado: (2016)

SUN-069 A 14 Year Old Female with Primary Amenorrhea
por: Chakravarthy, Varshini, et al.
Publicado: (2020)

Maraviroc: a review of its use in HIV infection and beyond
por: Woollard, Shawna M, et al.
Publicado: (2015)

Incidence of ischemic cardiovascular events in the maraviroc clinical development program
por: Portsmouth, S, et al.
Publicado: (2010)

Obsessive–compulsive symptoms in ACTG1-associated Baraitser-Winter cerebrofrontofacial syndrome
por: Göbel, Theresa, et al.
Publicado: (2022)

Obstetric risk in pregnancy interacts with hair cortisone levels to reduce gestational length
por: Musana, Joseph, et al.
Publicado: (2022)

De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome
por: Rivière, Jean-Baptiste, et al.
Publicado: (2012)

O069 The effects of sleep disordered breathing on sleep spindle activity in children and the relationship with neurocognition
por: Shetty, M, et al.
Publicado: (2022)

Immunologic impact of maraviroc in clinical practice of a university hospital
por: Paniagua, S Plata, et al.
Publicado: (2010)

Pseudo-obstruction–inducing ACTG2(R257C) alters actin organization and function
por: Hashmi, Sohaib Khalid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rtp2rqvllsa3rsnb4uk6j4utci